Company intelligence / Profile preview

Kindstar Globalgene Technology

Ownership: Private
Employees: ~3011
Development stage: Other

Overview

Kindstar Globalgene Technology operates one of China’s largest specialty/esoteric clinical testing service networks. It offers over a thousand in-house developed and licensed tests across hematology, oncology, genetics and more. The company serves over three thousand hospitals—including all top twenty hospitals in China—and continues to expand its portfolio through R&D and acquisitions. Revenue reached RMB930.67 million in FY2021 with continued growth from non-COVID specialty testing.

Therapeutic areas: Rare DiseasesNeurologyInfectious DiseasesHematologyOncologyWomen's Health
Modalities: Diagnostic test/service
Industry: Molecular Diagnostics

Partnerships

Mayo Clinic – six-year strategic cooperation agreement to introduce high-end esoteric tests into China; ongoing collaboration since at least early-mid 2010s.Novartis – signed strategic cooperation agreement.

Beyond the preview

Go deeper on Kindstar Globalgene Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kindstar Globalgene Technology.

Explore the full profile